Emerging evidence showed that CSCs exhibiting excessive Bmi-1 levels were increasingly resistant to chemotherapy.[42–44] Collectively, these studies implied that Bmi-1 might be a potential therapeutic target for cancer. This evidence concerns the gene BMI1 and cancer.